Novartis AG (NVS) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novartis Ag.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:05.213 Good afternoon and welcome to the Novartis Q2 2026 results release conference call 00:00:05.213 -- 00:00:09.616 and live webcast. Please note that during the presentation, all participants will be 00:00:09.616 -- 00:00:13.197 in a listen-only mode and the conference is being recorded. 00:00:13.197 -- 00:00:17.799 After the presentation, there'll be an opportunity to ask questions by pressing star 00:00:17.799 -- 00:00:20.941 1 and 1 at any time during the conference. 00:00:20.941 -- 00:00:26.135 Please limit yourself to one question and return to the queue for any follow-up. 00:00:26.135 -- 00:00:30.319 A recording of the conference call, including the Q&A session, will be available on our 00:00:30.319 -- 00:00:35.303 website shortly after the call ends. With that, I would like to hand over to Mr. 00:00:35.303 -- 00:00:40.768 Nigel Trotman, Head Business Planning and Analysis and Digital Finance. 00:00:40.768 -- 00:00:43.030 Please go ahead, sir. 00:00:43.030 -- 00:00:48.155 Thank you, Sharon. Good morning and good afternoon and welcome everyone to our Q2 2026 00:00:48.155 -- 00:00:53.157 conference call. The information presented today contains forward-looking statements, 00:00:53.157 -- 00:00:57.619 that involve known and unknown risks, uncertainties and other factors. 00:00:57.619 -- 00:01:02.260 These may cause actual results to be materially different from any future results, performance 00:01:02.260 -- 00:01:06.082 or achievements expressed or implied by such statements. 00:01:06.082 -- 00:01:10.824 For description of some of these factors, please refer to the company's Form 20F and 00:01:10.824 -- 00:01:15.846 its most recent quarterly results on Form 6K that respectively were filed 00:01:15.846 -- 00:01:20.244 with and furn...